Able 0 4 0 4 O
to 5 7 5 7 O
receive 8 15 8 15 O
granulocyte 16 27 16 27 B-treatment
colony 28 34 28 34 I-treatment
- 34 35 34 35 I-treatment
stimulating 35 46 35 46 I-treatment
factor 47 53 47 53 I-treatment
( 54 55 54 55 I-treatment
G 55 56 55 56 I-treatment
- 56 57 56 57 I-treatment
CSF 57 60 57 60 I-treatment
) 60 61 60 61 I-treatment
and 62 65 62 65 O
undergo 66 73 66 73 O
apheresis 74 83 74 83 B-treatment
either 84 90 84 90 O
through 91 98 91 98 O
placement 99 108 99 108 B-treatment
of 109 111 109 111 I-treatment
catheters 112 121 112 121 I-treatment
in 122 124 122 124 I-treatment
antecubital 125 136 125 136 I-treatment
veins 137 142 137 142 I-treatment
or 143 145 143 145 O
a 146 147 146 147 O
temporary 148 157 148 157 B-treatment
central 158 165 158 165 I-treatment
venous 166 172 166 172 I-treatment
catheter 173 181 173 181 I-treatment
OR 182 184 182 184 O
agrees 185 191 185 191 O
on 192 194 192 194 O
a 195 196 195 196 O
bone 197 201 197 201 B-treatment
marrow 202 208 202 208 I-treatment
harvest 209 216 209 216 I-treatment

Healthy 0 7 217 224 O
as 8 10 225 227 O
per 11 14 228 231 O
donor 15 20 232 237 O
selection 21 30 238 247 O
screening 31 40 248 257 O
( 41 42 258 259 O
following 42 51 259 268 O
current 52 59 269 276 O
SOP 60 63 277 280 O
based 64 69 281 286 O
on 70 72 287 289 O
standards 73 82 290 299 O
of 83 85 300 302 O
foundation 86 96 303 313 O
for 97 100 314 317 O
accreditation 101 114 318 331 O
of 115 117 332 334 O
cellular 118 126 335 343 B-treatment
therapy 127 134 344 351 I-treatment
and 135 138 352 355 O
stem 139 143 356 360 B-treatment
cell 144 148 361 365 I-treatment
transplantation 149 164 366 381 I-treatment
- 165 166 382 383 O
FACT 167 171 384 388 O
) 171 172 388 389 O

Participant 0 11 390 401 O
age 12 15 402 405 B-age
is 16 18 406 408 O
0 19 20 409 410 B-lower_bound
( 21 22 411 412 O
newborn 22 29 412 419 O
) 29 30 419 420 O
to 31 33 421 423 O
35 34 36 424 426 B-upper_bound
years 37 42 427 432 I-upper_bound
- 42 43 432 433 O
old 43 46 433 436 O

Participant 0 11 437 448 O
does 12 16 449 453 O
not 17 20 454 457 O
qualify 21 28 458 465 O
for 29 32 466 469 O
an 33 35 470 472 O
allogeneic 36 46 473 483 B-treatment
transplant 47 57 484 494 I-treatment
due 58 61 495 498 O
to 62 64 499 501 O
medical 65 72 502 509 O
screening 73 82 510 519 O
, 82 83 519 520 O
underlying 84 94 521 531 O
disease 95 102 532 539 O
, 102 103 539 540 O
or 104 106 541 543 O
lack 107 111 544 548 O
of 112 114 549 551 O
alternative 115 126 552 563 O
donors 127 133 564 570 O

Participant 0 11 571 582 O
has 12 15 583 586 O
a 16 17 587 588 O
disorder 18 26 589 597 O
affecting 27 36 598 607 O
the 37 40 608 611 O
hematopoietic 41 54 612 625 O
system 55 61 626 632 O
that 62 66 633 637 O
are 67 70 638 641 O
inherited 71 80 642 651 O
, 80 81 651 652 O
acquired 82 90 653 661 O
, 90 91 661 662 O
or 92 94 663 665 O
a 95 96 666 667 O
result 97 103 668 674 O
from 104 108 675 679 O
the 109 112 680 683 O
myeloablative 113 126 684 697 B-treatment
treatment 127 136 698 707 I-treatment
that 137 141 708 712 O
can 142 145 713 716 O
benefit 146 153 717 724 O
from 154 158 725 729 O
alternative 159 170 730 741 B-treatment
stem 171 175 742 746 I-treatment
cell 176 180 747 751 I-treatment
transplantation 181 196 752 767 I-treatment
according 197 206 768 777 O
to 207 209 778 780 O
standard 210 218 781 789 O
practice 219 227 790 798 O
guidelines 228 238 799 809 O
for 239 242 810 813 O
including 243 252 814 823 O
patients 253 261 824 832 O
for 262 265 833 836 O
transplant 266 276 837 847 O

Participant 0 11 848 859 O
must 12 16 860 864 O
lack 17 21 865 869 O
a 22 23 870 871 O
healthy 24 31 872 879 O
, 31 32 879 880 O
HLA 33 36 881 884 O
- 36 37 884 885 O
identical 37 46 885 894 O
related 47 54 895 902 O
or 55 57 903 905 O
unrelated 58 67 906 915 O
donor 68 73 916 921 O
unless 74 80 922 928 O
s 81 82 929 930 O
/ 82 83 930 931 O
he 83 85 931 933 O
has 86 89 934 937 O
a 90 91 938 939 O
borderline 92 102 940 950 O
organ 103 108 951 956 O
function 109 117 957 965 O
that 118 122 966 970 O
will 123 127 971 975 O
preclude 128 136 976 984 O
the 137 140 985 988 O
recipient 141 150 989 998 O
from 151 155 999 1003 O
receiving 156 165 1004 1013 O
a 166 167 1014 1015 O
curative 168 176 1016 1024 B-treatment
therapy 177 184 1025 1032 I-treatment
due 185 188 1033 1036 O
to 189 191 1037 1039 O
the 192 195 1040 1043 O
need 196 200 1044 1048 O
of 201 203 1049 1051 O
post 204 208 1052 1056 B-treatment
- 208 209 1056 1057 I-treatment
HSCT 209 213 1057 1061 I-treatment
immunosuppressive 214 231 1062 1079 I-treatment
therapy 232 239 1080 1087 I-treatment

Participant 0 11 1088 1099 O
's 11 13 1099 1101 O
medical 14 21 1102 1109 O
screening 22 31 1110 1119 O
clears 32 38 1120 1126 O
s 39 40 1127 1128 O
/ 40 41 1128 1129 O
he 41 43 1129 1131 O
for 44 47 1132 1135 O
allogeneic 48 58 1136 1146 B-treatment
transplantation 59 74 1147 1162 I-treatment
as 75 77 1163 1165 O
per 78 81 1166 1169 O
current 82 89 1170 1177 O
institutional 90 103 1178 1191 O
SOP 104 107 1192 1195 O
based 108 113 1196 1201 O
on 114 116 1202 1204 O
standards 117 126 1205 1214 O
of 127 129 1215 1217 O
foundation 130 140 1218 1228 O
for 141 144 1229 1232 O
accreditation 145 158 1233 1246 O
of 159 161 1247 1249 O
cellular 162 170 1250 1258 B-treatment
therapy 171 178 1259 1266 I-treatment
and 179 182 1267 1270 O
stem 183 187 1271 1275 B-treatment
cell 188 192 1276 1280 I-treatment
transplantation 193 208 1281 1296 I-treatment
( 209 210 1297 1298 O
FACT 210 214 1298 1302 O
) 214 215 1302 1303 O

